Quốc gia: Úc
Ngôn ngữ: Tiếng Anh
Nguồn: Department of Health (Therapeutic Goods Administration)
Sertraline hydrochloride
Ranbaxy Australia Pty Ltd
Medicine Registered
SETRONA CMI V5 May 2011 Page 1 of 11 SETRONA _SERTRALINE HYDROCHLORIDE TABLETS_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about SETRONA (sertraline). It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking SETRONA against the benefits it is expected to have for you. IF YOU HAVE ANY CONCERNS ABOUT USING/TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. Keep this leaflet with this medicine. You may need to read it again. WHAT SETRONA TABLET IS USED FOR SETRONA tablets contain the active ingredient sertraline. Sertraline belongs to a group of medicines known as selective serotonin reuptake inhibitors (SSRIs). These medicines are thought to work by increasing the activity of the chemical serotonin in the brain. SETRONA tablets are used to treat the following conditions: SETRONA is used to treat depression and conditions called obsessive compulsive disorder (OCD), panic disorder, social phobia (social anxiety disorder) and premenstrual dysphoric disorder (PMDD). Depression is longer lasting and/or more severe than the “low moods” everyone has from time to time due to the stress of everyday life. It is thought to be caused by a chemical imbalance in parts of the brain. This imbalance affects your whole body and can cause emotional and physical symptoms such as feeling low in spirit, loss of interest in activities, being unable to enjoy life, poor appetite or overeating, disturbed sleep, often waking up early, loss of sex drive, lack of energy and feeling guilty over nothing. SETRONA corrects this Đọc toàn bộ tài liệu
SETRONA PI V10 Apr 11 Page 1 of 25 SETRONA ( SERTRALINE HYDROCHLORIDE TABLETS ) NAME OF THE MEDICINE Sertraline Hydrochloride _CAS Number:_ 79559-97-0 DESCRIPTION SETRONA tablets contain (1S, 4S)-4-(3, 4-dichlorophenyl)-1, 2, 3, 4-tetrahydro-N- methyl-1-naphthalenamine hydrochloride. The empirical formula of sertraline hydrochloride is C 17 H 17 NCl 2 •HCl and its molecular weight is 342.7. Its structure is: Sertraline hydrochloride is a white crystalline powder that is slightly soluble in water and isopropyl alcohol and sparingly soluble in ethanol. SETRONA tablets contain the following inactive ingredients: microcrystalline cellulose, calcium hydrogen phosphate, sodium starch glycollate (Type A), hydroxy propyl cellulose, magnesium stearate. FILM COATING MATERIAL: OPADRY OY-S-58910 WHITE -Hypromellose, titanium dioxide (E171), macrogol 400, purified talc. PHARMACOLOGY MECHANISM OF ACTION The mechanism of action of sertraline is presumed to be linked to its inhibition of CNS neuronal uptake of serotonin (5HT). Studies at clinically relevant doses in man have demonstrated that sertraline blocks the uptake of serotonin into human platelets. _In vitro_ studies in animals also suggest that sertraline is a potent and selective inhibitor of neuronal serotonin reuptake and has only very weak effects on noradrenaline and dopamine neuronal reuptake. _In vitro_ studies have shown that SETRONA PI V10 Apr 11 Page 2 of 25 sertraline has no significant affinity to adrenergic ( 1 , 2 , ) choli Đọc toàn bộ tài liệu